## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `tb-500-stimulants`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/tb-500-stimulants/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tb-500-stimulants/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tb-500-stimulants/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tb-500-stimulants/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tb-500-stimulants/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `tb-500-stimulants` v2 · content_hash `df502fdb61d0ec09…` · thread_head genesis · 31 DIVs
- **thesis (c1):** Semax is studied for BDNF upregulation in animal models relevant to cognitive fatigue.
  - c2 [human/active] Selank shows anxiolytic effects comparable to low-dose benzodiazepines in small human studies without sedation.
  - c3 [preclinical/active] DSIP has been examined in old studies for sleep and withdrawal symptom support.
  - c4 [preclinical/active] TB-500/thymosin beta-4 promotes cell migration and inflammation modulation in animal tissue injury models.
  - c5 [mechanistic/active] No large human RCTs exist for these peptides specifically with amphetamine load.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/tb-500-stimulants/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tb-500-stimulants/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `tb-500-stimulants`
- **title:** TB-500 for Stimulant Load (Adderall/Amphetamine): Evidence on Repair Layers with Semax, Selank, DSIP
- **url:** https://miscsubjects.com/a/tb-500-stimulants
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:19.193Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have Stimulant load (Adderall / amphetamine)

Amphetamines force dopamine and norepinephrine release. This borrows focus now but can deplete stores over time. Sleep, appetite, and gut lining often suffer. Less regeneration window follows. Chronic load can deplete neurochemistry and stress the gut-brain axis.

Degenerative layers include:
- Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.
- Sleep: Stimulants delay onset and cut deep sleep stages.
- Gut: Stress on mucosa raises inflammation that affects mood and cognition.
- Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.

Breakdown outruns repair in these layers. Peptides here are studied for targeted repair pathways rather than symptom masking.

## Why Semax might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.
3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms. (mechanistic, from animal data on BDNF upregulation and dopamine modulation).
4. Therefore for you: If that neural/cognitive layer is part of your problem, Semax is discussed because it targets repair — not because it masks pain.

## Why Selank might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. Layer breaking down: Anxiety — Arousal without calm leads to jitter, rumination, non-restorative stress.
3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation. (preclinical and limited human anxiety studies).
4. Therefore for you: If that anxiety/neurochemistry layer is part of your problem, Selank is discussed because it targets repair — not because it masks pain.

## Why DSIP might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. Layer breaking down: Sleep — Stimulants delay onset and cut deep sleep.
3. What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion. (preclinical on sleep and withdrawal models).
4. Therefore for you: If that sleep/repair window layer is part of your problem, DSIP is discussed because it targets repair — not because it masks pain.

## Why TB-500 might help you

1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
2. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.
3. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure. (preclinical animal tissue repair and inflammation modulation).
4. Therefore for you: If that inflammation clearance/repair-cell migration layer is part of your problem, TB-500 is discussed because it targets repair — not because it masks pain.

## Why Amphetamine stimulants matters for you

Drug: Amphetamine stimulants.
What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.
Therefore for you: This drug suppresses signals temporarily but trades off repair by reducing sleep and gut recovery windows. It does not reduce mechanical load or support long-term regeneration.

## How these fit together

Neural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP), and inflammation clearance/repair-cell migration (TB-500) each target a stimulant-degeneration layer.
- Semax targets neural/cognitive.
- Selank targets anxiety/neurochemistry.
- DSIP targets sleep/repair window.
- TB-500 targets inflammation clearance/repair-cell migration.

The stack addresses separate layers without overlap. Semax builds neural connections after dopamine stress. Selank supports calm without sedation. DSIP opens the sleep window stimulants close. TB-500 aids cell migration for any tissue-level inflammation from chronic load. Together they map to dopamine depletion, anxiety, sleep loss, and inflammation.

## What the evidence actually shows

Human data is limited across all. Semax has Russian clinical reports on BDNF increases and attention in stroke patients (preclinical/animal dominant elsewhere). Selank has small human anxiety trials showing effects comparable to low-dose benzodiazepines without sedation. DSIP has old small studies on sleep and withdrawal syndromes. TB-500/thymosin beta-4 has extensive animal tissue healing data but no human clinical trials for these uses. (human: limited for Semax/Selank; preclinical: majority for all; anecdotal: common on forums.)

## What scientists say

Researchers note Semax augments psychostimulant effects on dopamine while raising BDNF in rodents. Selank modulates GABA without typical benzo side effects in animal models. DSIP interacts with amphetamine effects on temperature and locomotion in rats depending on dose and environment. Thymosin beta-4 promotes actin sequestration and cell migration in injury models. No large human RCTs exist for stimulant load specifically. Evidence remains mechanistic or from unrelated conditions.

## What people say on Reddit

Users report Semax for focus support post-stimulant crash with variable subjective cognitive lift. Selank anecdotes describe reduced jitter without drowsiness. DSIP threads mention deeper sleep during withdrawal periods. TB-500 posts focus on general recovery and reduced inflammation rather than direct stimulant effects. All remain self-reported and unverified.

## What people say on X

Posts discuss Semax as a potential BDNF support alongside or after Adderall. Selank mentioned for calm during high-arousal periods. DSIP for sleep aid in stimulant users. TB-500 highlighted for tissue repair in active individuals. Anecdotes emphasize individual experimentation; no controlled data shared.

## What we do not know

No direct human trials combine these peptides with amphetamines or measure outcomes on dopamine depletion, gut inflammation, or long-term tolerance. Optimal sequencing, duration, or interactions unknown. Effects on stimulant-specific neurochemistry untested in controlled settings.

## Safety and limits

All listed as research compounds with varying regulatory status. Human safety data sparse outside limited anxiety studies for Selank. Animal data suggests low acute toxicity for most but long-term effects unstudied. Individual responses vary widely. Consult qualified professionals for any health decisions. No claims of treatment or cure.

## Claims (5)

- **c2** [human w=0.8] Selank shows anxiolytic effects comparable to low-dose benzodiazepines in small human studies without sedation.
  - who_claims: grok/grok-4.3
  - sources: s9
- **c1** [preclinical w=0.5] Semax is studied for BDNF upregulation in animal models relevant to cognitive fatigue.
  - who_claims: grok/grok-4.3
  - sources: s15
- **c3** [preclinical w=0.5] DSIP has been examined in old studies for sleep and withdrawal symptom support.
  - who_claims: grok/grok-4.3
  - sources: s20
- **c4** [preclinical w=0.5] TB-500/thymosin beta-4 promotes cell migration and inflammation modulation in animal tissue injury models.
  - who_claims: grok/grok-4.3
  - sources: s2
- **c5** [mechanistic w=0.3] No large human RCTs exist for these peptides specifically with amphetamine load.
  - who_claims: grok/grok-4.3
  - sources: s1

## Voxel graph (5 atoms · 10 edges)
- full graph: https://miscsubjects.com/api/articles/tb-500-stimulants/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (5)
- chain valid: yes · head: `aa6c8e48c09aab04`

### s1 · pubmed · ok
- title: Utilizing Developmentally Essential Secreted Peptides Such as Thymosin Beta-4
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050/
- summary: TB4 review noting regenerative potential but limits.
- quote: In this review, we introduce Thymosin beta-4, a 43aa secreted peptide fulfilling our hopes and capable of numerous regenerative achievements via systemic administration
- claim_ids: c5
- hash: `aa6c8e48c09aab04`

### s2 · other · ok
- title: TB4 and TB-500 Peptide Therapy | What to Know in 2026
- url: https://www.innerbody.com/thymosin-beta-4-and-tb-500
- summary: TB-500 animal and preclinical repair evidence.
- quote: Researchers also note that TB4 is critical for the repair and regeneration of eye, heart, skin, nerve, and brain tissue after injury.
- claim_ids: c4
- hash: `4db2e79f5ce6a696`

### s9 · pubmed · ok
- title: Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety
- url: https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/
- summary: Selank anxiolytic data in context of benzodiazepines.
- quote: It was shown that the anxiolytic effect of Selank is comparable to that of classical benzodiazepine drugs
- claim_ids: c2
- hash: `84219383a521bd71`

### s15 · pubmed · ok
- title: Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome
- url: https://pubmed.ncbi.nlm.nih.gov/16996699/
- summary: Animal data on Semax, BDNF, and psychostimulants.
- quote: Evidence from animal studies revealed that Semax can augment the effects of psychostimulants on central dopamine release and also stimulates central brain-derived neurotrophic factor (BDNF) synthesis.
- claim_ids: c1
- hash: `20d45810af6ca4ff`

### s20 · pubmed · ok
- title: DSIP in the treatment of withdrawal syndromes from alcohol and opiates
- url: https://pubmed.ncbi.nlm.nih.gov/6548969/
- summary: DSIP and withdrawal/sleep studies.
- quote: The hypothesis for this therapeutic use of delta sleep-inducing peptide (DSIP) was based on several animal studies
- claim_ids: c3
- hash: `43945430fea7362b`

## Provenance (2 model passes)
- chain valid: yes · head: `45aff8f10ba2ff14`

- write · grok/grok-4.3 · 2026-06-29T23:30 · hash `9a9aac33183b`
- voxel_divide · owner · 2026-07-17T02:42 · hash `45aff8f10ba2`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/tb-500-stimulants/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/tb-500-stimulants/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tb-500-stimulants","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tb-500-stimulants|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tb-500-stimulants|tier|assertion`
- **iMessage ask:** `tb-500-stimulants|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `tb-500-stimulants`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tb-500-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tb-500-stimulants/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*